The Food and Drug Administration recently released draft guidance outlining the regulatory agency’s recommendations on design considerations for manufacturers seeking to develop interoperable medical devices. However, critics argue that the guidelines are not enough to ensure device interoperability.

The FDA guidance is meant to provide the industry with a “reasonable assurance of safety and effectiveness of their interoperable medical devices,” according to Bakul Patel, associate director of digital health in the FDA’s Center for Devices and Radiological Health.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access